1、Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment
epitheliopathy[ J]. Retina, 2013, 33(8): 1659-1672.Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment
epitheliopathy[ J]. Retina, 2013, 33(8): 1659-1672.
2、Phasukkijwatana N, Freund KB, Dolz-Marco R, et al. Peripapillary
pachychoroid syndrome[ J]. Retina, 2018, 38(9): 1652-1667.Phasukkijwatana N, Freund KB, Dolz-Marco R, et al. Peripapillary
pachychoroid syndrome[ J]. Retina, 2018, 38(9): 1652-1667.
3、Cheung CMG, Lee WK, Koizumi H, et al. Pachychoroid disease[ J].
Eye, 2019, 33(1): 14-33.Cheung CMG, Lee WK, Koizumi H, et al. Pachychoroid disease[ J].
Eye, 2019, 33(1): 14-33.
4、Lee WK, Baek J, Dansingani KK, et al. Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal
subfoveal choroidal thickness[ J]. Retina, 2016, 36(Suppl 1): S73-S82.Lee WK, Baek J, Dansingani KK, et al. Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal
subfoveal choroidal thickness[ J]. Retina, 2016, 36(Suppl 1): S73-S82.
5、Manayath GJ, Shah VS, Saravanan VR, et al. Polypoidal choroidal
vasculopathy associated with central serous chorioretinopathy:
pachychoroid spectrum of diseases[ J]. Retina, 2018, 38(6): 1195-
1204.Manayath GJ, Shah VS, Saravanan VR, et al. Polypoidal choroidal
vasculopathy associated with central serous chorioretinopathy:
pachychoroid spectrum of diseases[ J]. Retina, 2018, 38(6): 1195-
1204.
6、Dansingani KK, Balaratnasingam C, Naysan J, et al. En face imaging of
pachychoroid spectrum disorders with swept-source optical coherence
tomography[ J]. Retina, 2016, 36(3): 499-516.Dansingani KK, Balaratnasingam C, Naysan J, et al. En face imaging of
pachychoroid spectrum disorders with swept-source optical coherence
tomography[ J]. Retina, 2016, 36(3): 499-516.
7、Yang L, Jonas JB, Wei W. Choroidal vessel diameter in central serous
chorioretinopathy[ J]. Acta Ophthalmol, 2013, 91(5): e358-e362.Yang L, Jonas JB, Wei W. Choroidal vessel diameter in central serous
chorioretinopathy[ J]. Acta Ophthalmol, 2013, 91(5): e358-e362.
8、Agrawal R, Chhablani J, Tan KA, et al. Choroidal vascularity index in
central serous chorioretinopathy[ J]. Retina, 2016, 36(9): 1646-1651.Agrawal R, Chhablani J, Tan KA, et al. Choroidal vascularity index in
central serous chorioretinopathy[ J]. Retina, 2016, 36(9): 1646-1651.
9、Ting DSW, Yanagi Y, Agrawal R, et al. Choroidal remodeling in age-related macular degeneration and polypoidal choroidal vasculopathy: a
12-month prospective study[ J]. Sci Rep, 2017, 7(1): 7868.Ting DSW, Yanagi Y, Agrawal R, et al. Choroidal remodeling in age-related macular degeneration and polypoidal choroidal vasculopathy: a
12-month prospective study[ J]. Sci Rep, 2017, 7(1): 7868.
10、Ersoz MG, Arf S, Hocaoglu M, et al. Indocyanine green angiography of
pachychoroid pigment epitheliopathy[ J]. Retina, 2018, 38(9): 1668-
1674.Ersoz MG, Arf S, Hocaoglu M, et al. Indocyanine green angiography of
pachychoroid pigment epitheliopathy[ J]. Retina, 2018, 38(9): 1668-
1674.
11、Gaw%C4%99cki%20M%2C%20Grzybowski%20A%2C%20%C5%9Awi%C4%99ch%20A.%20Biometric%20risk%20factors%20for%20central%20%0Aserous%20chorioretinopathy%5B%20J%5D.%20Ophthalmol%20Ther%2C%202023%2C%2012(2)%3A%201327-%0A1338.Gaw%C4%99cki%20M%2C%20Grzybowski%20A%2C%20%C5%9Awi%C4%99ch%20A.%20Biometric%20risk%20factors%20for%20central%20%0Aserous%20chorioretinopathy%5B%20J%5D.%20Ophthalmol%20Ther%2C%202023%2C%2012(2)%3A%201327-%0A1338.
12、Meng Y, Xu Y, Li L, et al. Wide-field OCT-angiography assessment of
choroidal thickness and choriocapillaris in eyes with central serous
chorioretinopathy[ J]. Front Physiol, 2022, 13: 1008038.Meng Y, Xu Y, Li L, et al. Wide-field OCT-angiography assessment of
choroidal thickness and choriocapillaris in eyes with central serous
chorioretinopathy[ J]. Front Physiol, 2022, 13: 1008038.
13、Liu ZY, Li B, Xia S, et al. Analysis of choroidal morphology and
comparison of imaging findings of subtypes of polypoidal choroidal
vasculopathy: a new classification system[ J]. Int J Ophthalmol, 2020,
13(5): 731-736.Liu ZY, Li B, Xia S, et al. Analysis of choroidal morphology and
comparison of imaging findings of subtypes of polypoidal choroidal
vasculopathy: a new classification system[ J]. Int J Ophthalmol, 2020,
13(5): 731-736.
14、Chang YC, Cheng CK . Difference between pachychoroid and
nonpachychoroid polypoidal choroidal vasculopathy and their response
to anti-vascular endothelial growth factor therapy[ J]. Retina, 2020,
40(7): 1403-1411.Chang YC, Cheng CK . Difference between pachychoroid and
nonpachychoroid polypoidal choroidal vasculopathy and their response
to anti-vascular endothelial growth factor therapy[ J]. Retina, 2020,
40(7): 1403-1411.
15、Agrawal R, Gupta P, Tan KA, et al. Choroidal vascularity index as a
measure of vascular status of the choroid: measurements in healthy eyes
from a population-based study[ J]. Sci Rep, 2016, 6: 21090.Agrawal R, Gupta P, Tan KA, et al. Choroidal vascularity index as a
measure of vascular status of the choroid: measurements in healthy eyes
from a population-based study[ J]. Sci Rep, 2016, 6: 21090.
16、Ruiz-Moreno JM, Gutiérrez-Bonet R, Chandra A, et al. Choroidal
vascularity index versus choroidal thickness as biomarkers of acute
central serous chorioretinopathy[ J]. Ophthalmic Res, 2023, 66(1):
627-635.Ruiz-Moreno JM, Gutiérrez-Bonet R, Chandra A, et al. Choroidal
vascularity index versus choroidal thickness as biomarkers of acute
central serous chorioretinopathy[ J]. Ophthalmic Res, 2023, 66(1):
627-635.
17、Kaderli ST, Karalezli A, Kaderli A, et al. Evaluation of the choroidal
vascularity index after subthreshold yellow laser treatment in the
patients with chronic central serous chorioretinopathy[ J]. Eye, 2022,
36(9): 1826-1831.Kaderli ST, Karalezli A, Kaderli A, et al. Evaluation of the choroidal
vascularity index after subthreshold yellow laser treatment in the
patients with chronic central serous chorioretinopathy[ J]. Eye, 2022,
36(9): 1826-1831.
18、Kim JY, Son WY, Kim RY, et al. Recurrence and visual prognostic
factors of polypoidal choroidal vasculopathy: 5-year results[ J]. Sci Rep,
2021, 11(1): 21572.Kim JY, Son WY, Kim RY, et al. Recurrence and visual prognostic
factors of polypoidal choroidal vasculopathy: 5-year results[ J]. Sci Rep,
2021, 11(1): 21572.
19、Hwang BE, Kim JY, Kim RY, et al. En-face optical coherence
tomography hyperreflective foci of choriocapillaris in central serous
chorioretinopathy[ J]. Sci Rep, 2023, 13(1): 7184.Hwang BE, Kim JY, Kim RY, et al. En-face optical coherence
tomography hyperreflective foci of choriocapillaris in central serous
chorioretinopathy[ J]. Sci Rep, 2023, 13(1): 7184.
20、Shen M, Zhou H, Kim K, et al. Choroidal changes in eyes with
polypoidal choroidal vasculopathy after anti-VEGF therapy imaged
with swept-source OCT angiography[ J]. Invest Ophthalmol Vis Sci,
2021, 62(15): 5.Shen M, Zhou H, Kim K, et al. Choroidal changes in eyes with
polypoidal choroidal vasculopathy after anti-VEGF therapy imaged
with swept-source OCT angiography[ J]. Invest Ophthalmol Vis Sci,
2021, 62(15): 5.
21、Daizumoto E, Mitamura Y, Sano H, et al. Changes of choroidal
structure after intravitreal aflibercept therapy for polypoidal choroidal
vasculopathy[ J]. Br J Ophthalmol, 2017, 101(1): 56-61.Daizumoto E, Mitamura Y, Sano H, et al. Changes of choroidal
structure after intravitreal aflibercept therapy for polypoidal choroidal
vasculopathy[ J]. Br J Ophthalmol, 2017, 101(1): 56-61.
22、Kim RY, Chung DH, Kim M, et al. Use of choroidal vascularity index
for choroidal structural evaluation in central serous chorioretinopathy
with choroidal neovascularization[ J]. Retina, 2020, 40(7): 1395-1402.Kim RY, Chung DH, Kim M, et al. Use of choroidal vascularity index
for choroidal structural evaluation in central serous chorioretinopathy
with choroidal neovascularization[ J]. Retina, 2020, 40(7): 1395-1402.
23、Singh SR, Invernizzi A, Rasheed MA, et al. Wide-field choroidal vascular analysis in central serous chorioretinopathy[ J]. Eur J Ophthalmol, 2021, 31(5): 2520-2527.Singh SR, Invernizzi A, Rasheed MA, et al. Wide-field choroidal vascular analysis in central serous chorioretinopathy[ J]. Eur J Ophthalmol, 2021, 31(5): 2520-2527.
24、Yang J, Wang E, Yuan M, et al. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2020, 258(2): 241-247.Yang J, Wang E, Yuan M, et al. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2020, 258(2): 241-247.
25、Nishi O, Yasukawa T. Hydrodynamic analysis of the clinical findings in
pachychoroid-spectrum diseases[ J]. J Clin Med, 2022, 11(17): 5247.Nishi O, Yasukawa T. Hydrodynamic analysis of the clinical findings in
pachychoroid-spectrum diseases[ J]. J Clin Med, 2022, 11(17): 5247.
26、Han SY, Lee SH, Lee PK, et al. Choroidal morphology on ultra-widefield indocyanine green angiography and response to aflibercept in
pachychoroid neovasculopathy[ J]. Pharmaceuticals, 2023, 16(1): 73.Han SY, Lee SH, Lee PK, et al. Choroidal morphology on ultra-widefield indocyanine green angiography and response to aflibercept in
pachychoroid neovasculopathy[ J]. Pharmaceuticals, 2023, 16(1): 73.
27、Azuma K, Nomura Y, Kitamoto K, et al. Locational agreement of near-infrared autofluorescence with choroidal vascular hyperpermeability in
central serous chorioretinopathy[ J]. Retina, 2022, 42(11): 2203-2209.Azuma K, Nomura Y, Kitamoto K, et al. Locational agreement of near-infrared autofluorescence with choroidal vascular hyperpermeability in
central serous chorioretinopathy[ J]. Retina, 2022, 42(11): 2203-2209.
28、Yagi M, Miyake M, Mori Y, et al. Natural course of pachychoroid
pigment epitheliopathy[ J]. Ophthalmol Sci, 2022, 2(4): 100201.Yagi M, Miyake M, Mori Y, et al. Natural course of pachychoroid
pigment epitheliopathy[ J]. Ophthalmol Sci, 2022, 2(4): 100201.
29、Shiragami C, Takasago Y, Osaka R, et al. Clinical features of central
serous chorioretinopathy with type 1 choroidal neovascularization[ J].
Am J Ophthalmol, 2018, 193: 80-86.Shiragami C, Takasago Y, Osaka R, et al. Clinical features of central
serous chorioretinopathy with type 1 choroidal neovascularization[ J].
Am J Ophthalmol, 2018, 193: 80-86.
30、Jeong S, Kang W, Noh D, et al. Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2022, 260(6): 1887-1898.Jeong S, Kang W, Noh D, et al. Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2022, 260(6): 1887-1898.
31、Ramtohul P, Cabral D, Oh D, et al. En face Ultrawidefield OCT of
the Vortex Vein System in Central Serous Chorioretinopathy[ J].
Ophthalmol Retina, 2023, 7(4): 346-353.Ramtohul P, Cabral D, Oh D, et al. En face Ultrawidefield OCT of
the Vortex Vein System in Central Serous Chorioretinopathy[ J].
Ophthalmol Retina, 2023, 7(4): 346-353.
32、Liu B, Zhang X, Mi L, et al. Choroidal structure in subtypes of
polypoidal choroidal vasculopathy determined by binarization of
optical coherence tomographic images[ J]. Clin Exp Ophthalmol, 2019,
47(5): 631-637.Liu B, Zhang X, Mi L, et al. Choroidal structure in subtypes of
polypoidal choroidal vasculopathy determined by binarization of
optical coherence tomographic images[ J]. Clin Exp Ophthalmol, 2019,
47(5): 631-637.
33、Koizumi H, Yamagishi T, Yamazaki T, et al. Relationship between
clinical characteristics of polypoidal choroidal vasculopathy and
choroidal vascular hyperpermeability[ J]. Am J Ophthalmol, 2013,
155(2): 305-313.e1.Koizumi H, Yamagishi T, Yamazaki T, et al. Relationship between
clinical characteristics of polypoidal choroidal vasculopathy and
choroidal vascular hyperpermeability[ J]. Am J Ophthalmol, 2013,
155(2): 305-313.e1.
34、Baek J, Kook L, Lee WK . Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid[ J]. Sci Rep, 2019, 9(1): 5565.Baek J, Kook L, Lee WK . Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid[ J]. Sci Rep, 2019, 9(1): 5565.
35、Matet A, Daruich A, Hardy S, et al. Patterns of choriocapillaris flow
signal voids in central serous chorioretinopathy: an optical coherence
tomography angiography study[ J]. Retina, 2019, 39(11): 2178-2188.Matet A, Daruich A, Hardy S, et al. Patterns of choriocapillaris flow
signal voids in central serous chorioretinopathy: an optical coherence
tomography angiography study[ J]. Retina, 2019, 39(11): 2178-2188.
36、Spaide RF, Gemmy Cheung CM, Matsumoto H, et al. Venous overload choroidopathy: a hypothetical framework for central serous
chorioretinopathy and allied disorders[ J]. Prog Retin Eye Res, 2022,
86: 100973.Spaide RF, Gemmy Cheung CM, Matsumoto H, et al. Venous overload choroidopathy: a hypothetical framework for central serous
chorioretinopathy and allied disorders[ J]. Prog Retin Eye Res, 2022,
86: 100973.
37、Brinks J, van Dijk EHC, Meijer OC, et al. Choroidal arteriovenous
anastomoses: a hypothesis for the pathogenesis of central serous
chorioretinopathy and other pachychoroid disease spectrum
abnormalities[ J]. Acta Ophthalmol, 2022, 100(8): 946-959.Brinks J, van Dijk EHC, Meijer OC, et al. Choroidal arteriovenous
anastomoses: a hypothesis for the pathogenesis of central serous
chorioretinopathy and other pachychoroid disease spectrum
abnormalities[ J]. Acta Ophthalmol, 2022, 100(8): 946-959.
38、Matsumoto H, Hoshino J, Mukai R, et al. Vortex vein anastomosis at the watershed in pachychoroid spectrum diseases[ J]. Ophthalmol Retina, 2020, 4(9): 938-945.Matsumoto H, Hoshino J, Mukai R, et al. Vortex vein anastomosis at the watershed in pachychoroid spectrum diseases[ J]. Ophthalmol Retina, 2020, 4(9): 938-945.
39、Baek J, Lee JH, Jung BJ, et al. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2018, 256(12): 2309-2317.Baek J, Lee JH, Jung BJ, et al. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2018, 256(12): 2309-2317.
40、Demirel%20S%2C%20Yan%C4%B1k%20%C3%96%2C%20%C3%96zcan%20G%2C%20et%20al.%20A%20comparative%20study%20on%20the%20%0Achoroidal%20vascularity%20index%20and%20the%20determination%20of%20cut-off%20values%20%0Ain%20the%20pachychoroid%20spectrum%20diseases%5B%20J%5D.%20Jpn%20J%20Ophthalmol%2C%202021%2C%20%0A65(4)%3A%20482-491.Demirel%20S%2C%20Yan%C4%B1k%20%C3%96%2C%20%C3%96zcan%20G%2C%20et%20al.%20A%20comparative%20study%20on%20the%20%0Achoroidal%20vascularity%20index%20and%20the%20determination%20of%20cut-off%20values%20%0Ain%20the%20pachychoroid%20spectrum%20diseases%5B%20J%5D.%20Jpn%20J%20Ophthalmol%2C%202021%2C%20%0A65(4)%3A%20482-491.
41、Qiu B, Zhang X, Li Z, et al. Characterization of choroidal morphology
and vasculature in the phenotype of pachychoroid diseases by swept-source OCT and OCTA[ J]. J Clin Med, 2022, 11(11): 3243.Qiu B, Zhang X, Li Z, et al. Characterization of choroidal morphology
and vasculature in the phenotype of pachychoroid diseases by swept-source OCT and OCTA[ J]. J Clin Med, 2022, 11(11): 3243.
42、Matsumoto H, Hoshino J, Arai Y, et al. Quantitative measures of
vortex veins in the posterior pole in eyes with pachychoroid spectrum
diseases[ J]. Sci Rep, 2020, 10(1): 19505.Matsumoto H, Hoshino J, Arai Y, et al. Quantitative measures of
vortex veins in the posterior pole in eyes with pachychoroid spectrum
diseases[ J]. Sci Rep, 2020, 10(1): 19505.
43、Kishi S, Matsumoto H, Sonoda S, et al. Geographic filling delay of
the choriocapillaris in the region of dilated asymmetric vortex veins
in central serous chorioretinopathy[ J]. PLoS One, 2018, 13(11):
e0206646.Kishi S, Matsumoto H, Sonoda S, et al. Geographic filling delay of
the choriocapillaris in the region of dilated asymmetric vortex veins
in central serous chorioretinopathy[ J]. PLoS One, 2018, 13(11):
e0206646.
44、Ishikura M, Muraoka Y, Nishigori N, et al. Widefield choroidal
thickness of eyes with central serous chorioretinopathy examined by
swept-source OCT[ J]. Ophthalmol Retina, 2022, 6(10): 949-956.Ishikura M, Muraoka Y, Nishigori N, et al. Widefield choroidal
thickness of eyes with central serous chorioretinopathy examined by
swept-source OCT[ J]. Ophthalmol Retina, 2022, 6(10): 949-956.
45、Chung SE, Kang SW, Kim JH, et al. Engorgement of vortex vein and
polypoidal choroidal vasculopathy[ J]. Retina, 2013, 33(4): 834-840.Chung SE, Kang SW, Kim JH, et al. Engorgement of vortex vein and
polypoidal choroidal vasculopathy[ J]. Retina, 2013, 33(4): 834-840.
46、Jeong A, Lim J, Min S. Choroidal vascular abnormalities by ultra-widefield indocyanine green angiography in polypoidal choroidal
vasculopathy[ J]. Invest Ophthalmol Vis Sci, 2021, 62(2): 29.Jeong A, Lim J, Min S. Choroidal vascular abnormalities by ultra-widefield indocyanine green angiography in polypoidal choroidal
vasculopathy[ J]. Invest Ophthalmol Vis Sci, 2021, 62(2): 29.
47、Matsumoto H, Hoshino J, Mukai R, et al. Chronic choriocapillaris
ischemia in dilated vortex veinregion in pachychoroid
neovasculopathy[ J]. Sci Rep, 2021, 11(1): 16274.Matsumoto H, Hoshino J, Mukai R, et al. Chronic choriocapillaris
ischemia in dilated vortex veinregion in pachychoroid
neovasculopathy[ J]. Sci Rep, 2021, 11(1): 16274.
48、Hirooka K , Saito M, Yamashita Y, et al. Imbalanced choroidal circulation in eyes with asymmetric dilated vortex vein[ J]. Jpn J Ophthalmol, 2022, 66(1): 14-18.Hirooka K , Saito M, Yamashita Y, et al. Imbalanced choroidal circulation in eyes with asymmetric dilated vortex vein[ J]. Jpn J Ophthalmol, 2022, 66(1): 14-18.
49、Jung JJ, Yu DJG, Ito K, et al. Quantitative assessment of asymmetric
choroidal outflow in pachychoroid eyes on ultra-widefield indocyanine
green angiography[ J]. Invest Ophthalmol Vis Sci, 2020, 61(8): 50.Jung JJ, Yu DJG, Ito K, et al. Quantitative assessment of asymmetric
choroidal outflow in pachychoroid eyes on ultra-widefield indocyanine
green angiography[ J]. Invest Ophthalmol Vis Sci, 2020, 61(8): 50.
50、Zeng Q, Luo L, Yao Y, et al. Three-dimensional choroidal vascularity
index in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography[ J]. Front Med,
2022, 9: 967369.Zeng Q, Luo L, Yao Y, et al. Three-dimensional choroidal vascularity
index in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography[ J]. Front Med,
2022, 9: 967369.
51、Matsumoto H, Hoshino J, Mukai R, et al. Pulsation of anastomotic
vortex veins in pachychoroid spectrum diseases[ J]. Sci Rep, 2021,
11(1): 14942.Matsumoto H, Hoshino J, Mukai R, et al. Pulsation of anastomotic
vortex veins in pachychoroid spectrum diseases[ J]. Sci Rep, 2021,
11(1): 14942.
52、Byeon SH, Lew YJ, Lee SC, et al. Clinical features and follow-up
results of pulsating polypoidal choroidal vasculopathy treated with
photodynamic therapy[ J]. Acta Ophthalmol, 2010, 88(6): 660-668.Byeon SH, Lew YJ, Lee SC, et al. Clinical features and follow-up
results of pulsating polypoidal choroidal vasculopathy treated with
photodynamic therapy[ J]. Acta Ophthalmol, 2010, 88(6): 660-668.
53、Akaza E, Matsumoto Y, Yuzawa M. Pulsation in polypoidal choroidal
vasculopathy[ J]. Nippon Ganka Gakkai Zasshi, 2006, 110(4): 288-
292.Akaza E, Matsumoto Y, Yuzawa M. Pulsation in polypoidal choroidal
vasculopathy[ J]. Nippon Ganka Gakkai Zasshi, 2006, 110(4): 288-
292.
54、李青楠, 刘炯, 杨光, 等. 息肉样脉络膜血管病变患者脉络膜血管系统及涡静脉影像学表现分析[ J]. 医学影像学杂志, 2022, 32(12): 2067-2070.
Li QN, Liu J, Yang G, et al. Analysis of changes of choroidal vascular
system and vortex vein related imaging findings in patients with
polypoid choroidal vascular disease[ J]. J Med Imag, 2022, 32(12):
2067-2070.李青楠, 刘炯, 杨光, 等. 息肉样脉络膜血管病变患者脉络膜血管系统及涡静脉影像学表现分析[ J]. 医学影像学杂志, 2022, 32(12): 2067-2070.
Li QN, Liu J, Yang G, et al. Analysis of changes of choroidal vascular
system and vortex vein related imaging findings in patients with
polypoid choroidal vascular disease[ J]. J Med Imag, 2022, 32(12):
2067-2070.
55、Kilic D, Karahan M, Vural E, et al. Abnormal retrobulbar blood flow
variables in central serous chorioretinopathy[ J]. J Clin Ultrasound,
2020, 48(7): 405-409.Kilic D, Karahan M, Vural E, et al. Abnormal retrobulbar blood flow
variables in central serous chorioretinopathy[ J]. J Clin Ultrasound,
2020, 48(7): 405-409.
56、Spaide RF, Ledesma-Gil G, Gemmy Cheung CM. Intervortex venous
anastomosis in pachychoroid-RELATED disorders[ J]. Retina, 2021,
41(5): 997-1004.Spaide RF, Ledesma-Gil G, Gemmy Cheung CM. Intervortex venous
anastomosis in pachychoroid-RELATED disorders[ J]. Retina, 2021,
41(5): 997-1004.
57、Manayath%20GJ%2C%20Arora%20S%2C%20Parikh%20H%2C%20et%20al.%20Is%20myopia%20a%20protective%20factor%20%0Aagainst%20central%20serous%20chorioretinopathy%3F%5B%20J%5D.%20Int%20J%20Ophthalmol%2C%202016%2C%20%0A9(2)%3A%20266-270.Manayath%20GJ%2C%20Arora%20S%2C%20Parikh%20H%2C%20et%20al.%20Is%20myopia%20a%20protective%20factor%20%0Aagainst%20central%20serous%20chorioretinopathy%3F%5B%20J%5D.%20Int%20J%20Ophthalmol%2C%202016%2C%20%0A9(2)%3A%20266-270.
58、Terao N, Imanaga N, Wakugawa S, et al. Short axial length is related
to asymmetric vortex veins in central serous chorioretinopathy[ J].
Ophthalmol Sci, 2021, 1(4): 100071.Terao N, Imanaga N, Wakugawa S, et al. Short axial length is related
to asymmetric vortex veins in central serous chorioretinopathy[ J].
Ophthalmol Sci, 2021, 1(4): 100071.
59、Kishi S, Matsumoto H. A new insight into pachychoroid diseases: Remodeling of choroidal vasculature[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2022, 260(11): 3405-3417.Kishi S, Matsumoto H. A new insight into pachychoroid diseases: Remodeling of choroidal vasculature[ J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2022, 260(11): 3405-3417.
60、Ohno-Matsui K, Akiba M, Modegi T, et al. Association between shape
of sclera and myopic retinochoroidal lesions in patients with pathologic
myopia[ J]. Invest Ophthalmol Vis Sci, 2012, 53(10): 6046-6061.Ohno-Matsui K, Akiba M, Modegi T, et al. Association between shape
of sclera and myopic retinochoroidal lesions in patients with pathologic
myopia[ J]. Invest Ophthalmol Vis Sci, 2012, 53(10): 6046-6061.
61、Keidel LF, Schworm B, Langer, et al. Scleral thickness as a risk
factor for central serous chorioretinopathy and pachychoroid
neovasculopathy[ J]. J Clin Med, 2023, 12(9): 3102.Keidel LF, Schworm B, Langer, et al. Scleral thickness as a risk
factor for central serous chorioretinopathy and pachychoroid
neovasculopathy[ J]. J Clin Med, 2023, 12(9): 3102.
62、Imanaga N, Terao N, Sonoda S, et al. Relationship between
scleral thickness and choroidal str ucture in central serous
chorioretinopathy[ J]. Invest Ophthalmol Vis Sci, 2023, 64(1): 16.Imanaga N, Terao N, Sonoda S, et al. Relationship between
scleral thickness and choroidal str ucture in central serous
chorioretinopathy[ J]. Invest Ophthalmol Vis Sci, 2023, 64(1): 16.
63、Lee YJ, Lee YJ, Lee JY, et al. A pilot study of scleral thickness in central
serous chorioretinopathy using anterior segment optical coherence
tomography[ J]. Sci Rep, 2021, 11(1): 5872.Lee YJ, Lee YJ, Lee JY, et al. A pilot study of scleral thickness in central
serous chorioretinopathy using anterior segment optical coherence
tomography[ J]. Sci Rep, 2021, 11(1): 5872.
64、Spaide RF, Fisher YL, Ngo WK, et al. Regional scleral thickness as a
risk factor for central serous chorioretinopathy[ J]. Retina, 2022, 42(7):
1231-1237.Spaide RF, Fisher YL, Ngo WK, et al. Regional scleral thickness as a
risk factor for central serous chorioretinopathy[ J]. Retina, 2022, 42(7):
1231-1237.
65、Venkatesh P, Chawla R, Tripathy K, et al. Scleral resection in chronic
central serous chorioretinopathy complicated by exudative retinal
detachment[ J]. Eye Vis, 2016, 3(1): 23.Venkatesh P, Chawla R, Tripathy K, et al. Scleral resection in chronic
central serous chorioretinopathy complicated by exudative retinal
detachment[ J]. Eye Vis, 2016, 3(1): 23.
